ReviewCurrent medical science2026
Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions.
Review in Current medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Obesity and Eye Diseases.Nutrients · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trehalose, a naturally occurring disaccharide, is gaining recognition for its therapeutic potential across a wide range of disorders. This review highlights the increasing importance of trehalose in clinical research and its applications in disease management. The unique biochemical properties of trehalose, including its ability to increase stress resistance and protect cellular structures, make it a promising therapeutic agent for various pathological conditions. Trehalose has demonstrated potential in addressing metabolic disorders such as diabetes and obesity by regulating glucose homeostasis, improving insulin sensitivity, and modulating lipid metabolism. Additionally, it has shown promise in cancer treatment by inhibiting tumor growth and promoting cell death. Beneficial effects have also been observed in models of cardiovascular diseases, ocular and dental conditions, osteoarthritis, Niemann-Pick disease, and genetic disorders. While existing clinical studies provide valuable insights into the therapeutic potential of trehalose, further research is needed to optimize its dosage, elucidate its mechanisms of action, and conduct large-scale trials to establish its efficacy and safety. In conclusion, trehalose represents a promising therapeutic compound with broad applications, offering a compelling avenue for future research and the development of innovative treatment strategies.
Indexed as
Identifiers
41790392What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.